THE LONGIDAZA USING IN OPHTHALMOLOGY

Abstract

Clinical results and some medical difficulties in ophthalmology is straight connected with repairing processes and unpredictable cellular response. The opportunity of enzyme medicine using is associated with their ability to raise the therapeutic effect in different pathological cases in clinical practice. Often because of fibrin extra production the result of the disease could be unfavourable. Searching for the treatment method which could prevent fibrin extra production is the actual ophthalmological problem. Longidaza is a conjugate of enzyme hyaluronidase with high molecular weight azoximer, and it has an opportunity to lyse extra fibrin fibres, which was produced during the inflammation process after traumatic damage, surgical treatment. The efficiency of the using of enzyme medicines is reported in cornea pathological cases, and in vitreous body pathological cases, that could be a new conservative way for treatment. The advantages of longidaza are: atraumatic injections ways; minimal side-effects; no rehabilitation period; low price. According to ambiguous in opinions it is necessary to continue to research Longidaza.

Keywords

• лонгидаза
• гиалуронидаза
• энзимная терапия
• пролиферативный ответ
• фибринолиз